We’re thrilled to share that our CEO Jean-Philippe Combal will join a panel of key industry leaders at the 10th Annual LSX World Congress to provide insight on best practices, strategies and real-life experiences that drive innovation in cell and gene therapy (#CGT).
Vivet Therapeutics is dedicated to developing novel and long-lasting gene therapies for rare inherited metabolic disorders including #CTX and #WilsonDisease.
📣 Panel: Investing in a Sound CGT Clinical Strategy to Guarantee Funding Success
🎙 Track: Biotech Leaders, Capital Market & Investments
📅 Date & Time: 30th April 2024 at 12:00noon BST
📍 Location: Business Design Centre, London
Get in touch if you would like to connect at the #LSXWorldCongress to learn more about Vivet Therapeutics’ diversified pipeline and patented technologies by using the link in the first comment below.
The LSX World Congress stands as Europe’s foremost event, bringing together CEOs and senior decision makers from across the world’s most innovative #biopharma, #medtech and #healthtech companies together with investors, senior BD&L teams, R&D leaders and KOLs all dedicated to advancing healthcare and shaping the future of medicine.